胸腔积液中AFU和Tch联合检测在良恶性疾病鉴别诊断中的价值  

Value of AFU and Tch in Differential Diagnosis of Pleural Effusion

作　　者：李峰[1] 魏群[1] 陈恳[1] 张莉娜[1] 朱郁飞[1] 许可银[1] 张弘[1] 

机构地区：[1]南通大学附属医院消化内科,江苏南通226001

出　　处：《现代检验医学杂志》2012年第4期142-143,146,共3页Journal of Modern Laboratory Medicine

摘　　要：目的探讨胸腔积液中a-L-岩藻糖苷酶（AFU）、胆固醇（Tch）在良恶性疾病鉴别诊断的价值。方法用生化比色法检测临床上36例胸腔积液中AFU，Tch活性的变化。结果恶性胸腔积液AFU及Tch分别为（172．55士90．38）μmol／（L·h）和（1．66±0．91）mmol／L；良性胸腔积液AFU及Tch分别为（102．01±56．52）μmol／（L·h）和（O．71±0．61）mmol／L。恶性胸腔积液组AFU活性明显高于良性胸腔积液组，差异有统计学意义（P〈0．01，t=3．534）；恶性胸腔积液组Tch活性明显高于良性胸腔积液组，差异有统计学意义（P〈0．01，t=3．199）。以AFU119．5μmol／（L·h），Tch1．1mmol／L为界值测定恶性胸腔积液的敏感度、特异度分别为67．23％，75．02％和气72．12％，86．19％。两项联合检测的敏感度、特异度为78．62％和90．02％。结论胸腔积液中AFU和Tch的活性测定有助于恶性胸腔积液和非结核良性胸腔积液鉴别诊断，两者联合检测可提高良恶性胸腔积液鉴别诊断的敏感度和特异度。Objective To study the value a-L-Fueosidase（AFU） and Tehactivity（Tch） in the differential diagnosis of pleural effusion. Methods Of 36 cases,the activities of AFU and Tch of peritoneal fluid were tested by biochemical colorimetric method. Results In the malignant ascites group,the activity levers of AFU and Tch were （172.55±90.38） μmol/（L h） and（1.66±0. 91） mmol/L,respectively, in the benign ascites group, the activity levers of AFU and Tch were （102.01± 56.52） μmol/（L h） and （0. 71±0.61） mmol/L. AFU activity of malignant ascites group was obviously higher than that of the benign ascites group （ t= 3. 534, P〈0. 01）, as well as Tch, they both had the evident difference （ t= 3. 199, P〈0.01）. Established 119.5 μmol/（L h）. Has the boundary between the malignant and benign group for AFU,and 1.1 mmol/L for Tch. The sensitivity and specificity of AFU and Tch were 67.23% ,75.02% and 72.12% ,86.19% ,respectively. The sensi- tivity and specificity with two markers combination test were 78.62% and 90.02%. Conclusion Determination of AFU and Tch of pleural effusion is conductive to differential diagnosis of malignant and benign pleural effusion. Simultaneous determi- nation of AFU and Tch can improve the sensitivity and specificity in the differential diagnosis of pleural effusion.

关 键 词：A-L-岩藻糖苷酶 胆固醇 胸腔积液 鉴别诊断 

分 类 号：R561.3[医药卫生—呼吸系统] R446.112[医药卫生—内科学]